Effects of Alpha- Tocopherol on the Velocity of Low Density Lipoprotein Oxidation by Cupric Ions
,
Abstract
We studied the effect of different concentrations of alpha-tocopherol on in vitro cupric ions induced oxidation of low density lipoproteins (LDL). Human native LDL (50 µg protein/ml) oxidation was induced by 10 µmol/L of CuSO4. Conjugated dienes were measured spectrophotometrically for up to 440 minutes. The length of the lag phase (Tlag), maximum velocity of the reaction (Vmax) and the maximum amount of generated dienes were obtained from kinetic data. Alpha-tocopherol increased Tlag and decreased Vmax with a dependence upon concentration (0-100 µmol/L). There was no difference between the Dmax obtained with cupric ions alone or in the presence of the various concentrations of alpha-tocopherol. The results suggest that alpha-tocopherol may decrease free radicals presence in LDL and thus decrease velocity of LDL oxidation by cupric ions. This mechanism may be a reason for alpha-tocopherol effect in ameliorating atherosclerosis.
Chisolm GM, Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med 2000;28(12):1815-26
Vainio S, Ikonen E. Macrophage cholesterol transport: a critical player in foam cell formation. Ann Med 2003;35(3):146-55.
Mertens A, Verhamme P, Bielicki JK, Phillips MC, Quarck R, Verreth W, et al. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis. Circulation 2003;107(12):1640-6.
Aviram M, Kaplan M, Rosenblat M, Fuhrman B. Dietary antioxidants and paraoxonases against LDL oxidation and atherosclerosis development. Handb Exp Pharmacol 2005;(170):263-300.
Patterson RA, Lamb DJ, Leake DS. Mechanisms by which cysteine can inhibit or promote the oxidation of low density lipoprotein by copper. Atherosclerosism2003;169(1):87-94.
Esterbauer H, Gebicki J, Puhl H, Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992;13(4):341-90.
Bonnefont-Rousselot D, Chevé G, Gozzo A, Tailleux A, Guilloz V, Caisey S, et al. Melatonin related compounds inhibit lipid peroxidation during copper or free radicalinduced LDL oxidation. J Pineal Res 2002;33(2):109-17.
Upritchard JE, Sutherland WH, Mann JI. Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity= in type 2 diabetes. Diabetes Care 2000;23(6):733-8.
van Tits LJ, de Waart F, Hak-Lemmers HL, van Heijst P, de Graaf J, Demacker PN, et al. Effects of alphatocopherol on superoxide production and plasma intercellular adhesion molecule-1 and antibodies to oxidized LDL in chronic smokers. Free Radic Biol Med 2001;30(10):1122-9.
Carr AC, Zhu BZ, Frei B. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). Circ Res 2000;87(5):349-54.
Gieseg SP, Esterbauer H. Low density lipoprotein is saturable by pro-oxidant copper. FEBS Lett 1994;343(3):188-94.
Ghaffari MA, Saffari MR, Ghiasvand T. The effect of α- tocopherol on copper binding to low density lipoprotein. Iran J Pharma Res 2006;5(3):209-14.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement using the folin phenol reagent. J Biol Chem 1951;193(1):265-75.
Noble RP. Electrophoretic separation of plasma lipoproteins in agarose gel. J Lipid Res 1968;9(6):693-700.
Abuja PM, Albertini R. Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins. Clin Chim Acta. 2001;306(1-2):1-17.
Puhl H, Waeg G, Esterbauer H. Methods to determine oxidation of low-density lipoproteins. Methods Enzymol 1994;233:425-41.
Ziouzenkova O, Gieseg SP, Ramos P, Esterbauer H. Factors affecting resistance of low density lipoproteins to oxidation. Lipids 1996;31 Suppl:S71-6.
Pinchuk I, Gal S, Lichtenberg D. The dose-dependent effect of copper-chelating agents on the kinetics of peroxidation of low-density lipoprotein (LDL). Free Radic Res 2001;34(4):349-62.
Munteanu A, Zingg JM, Azzi A. Anti-atherosclerotic effects of vitamin E-myth or reality? J Cell Mol Med 2004;8(1):59-76.
Abudu N, Miller JJ, Attaelmannan M, Levinson SS. Vitamins in human arteriosclerosis with emphasis onvitamin C and vitamin E. Clin Chim Acta 2004;339(1-2):11-25.
Briante R, Febbraio F, Nucci R. Antioxidant/prooxidant effects of dietary non-flavonoid phenols on the Cu2+- induced oxidation of human low-density lipoprotein (LDL). Chem Biodivers 2004;1(11):1716-29.
Filipe P, Haigle J, Silva JN, Freitas J, Fernandes A, Mazière JC, et al. Anti- and pro-oxidant effects of quercetin in copper-induced low density lipoprotein oxidation. Quercetin as an effective antioxidant against pro-oxidant effects of urate. Eur J Biochem 2004;271(10):1991-9.
Filipe P, Haigle J, Freitas J, Fernandes A, Mazière JC, Mazière C, et al. Anti- and pro-oxidant effects of urate in copper-induced low-density lipoprotein oxidation. Eur J Biochem 2002;269(22):5474-83.
| Files | ||
| Issue | Vol 48, No 5 (2010) | |
| Section | Original Article(s) | |
| Keywords | ||
| Lipoprotein LDL cupric ions alpha- Tocopherol oxidation- reduction | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
